InfuSystems (INFU) vs Utah Medical Products (UTMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
InfuSystems (INFU) has outperformed Utah Medical Products (UTMD) over the past year, gaining 31.1% versus a gain of 16.2%. Over five years, INFU leads with a +3.6% price change compared with -18.4% for UTMD. InfuSystems is the larger company by market cap ($267.1 million vs $234.5 million), about 1.1 times the size.
On valuation, Utah Medical Products trades at a lower trailing P/E (22.5x vs 33.5x for InfuSystems). Utah Medical Products pays a dividend yielding 1.67%, while InfuSystems does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INFU | UTMD |
|---|---|---|
| Share price | $13.41 | $73.88 |
| Market cap | $267.09M | $234.47M |
| 1-day change | +0.60% | +0.58% |
| YTD return | +48.61% | +31.25% |
| 1-year return | +31.07% | +16.18% |
| 5-year return | +3.57% | -18.41% |
| P/E ratio (TTM) | 33.52 | 22.52 |
| Forward P/E | 25.79 | — |
| EPS (TTM) | $0.40 | $3.28 |
| Dividend yield | 0.00% | 1.67% |
| Annual dividend | $0.00 | $1.24 |
| 52-week high | $13.85 | $76.89 |
| 52-week low | $7.29 | $53.66 |
| Distance from 52-week high | -3.18% | -3.92% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +25.50% | — |
| Average volume | 139.81K | 34.21K |
| Shares outstanding | 19.92M | 3.17M |
| Employees | 461 | 140 |
| Sector | Health Care | Healthcare |
| Industry | Medical/Dental Instruments | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- INFU has outperformed UTMD by 14.9 percentage points over the past year.
- InfuSystems trades at a higher earnings multiple (33.5x vs 22.5x trailing P/E).
- Utah Medical Products offers a meaningfully higher dividend yield (1.67% vs 0.00%).
- The two companies sit in different sectors: InfuSystems in Health Care and Utah Medical Products in Healthcare.
About InfuSystems
INFU stock →InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions.
Health Care · Medical/Dental Instruments · 461 employees
About Utah Medical Products
UTMD stock →Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally.
Healthcare · Medical Instruments & Supplies · 140 employees
INFU vs UTMD FAQ
Which is bigger, InfuSystems or Utah Medical Products?
InfuSystems (INFU) is larger, with a market capitalization of $267.09M compared with $234.47M for Utah Medical Products (UTMD).
Which stock has performed better over the past year, INFU or UTMD?
INFU returned +31.07% over the past 12 months, compared with +16.18% for UTMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, INFU or UTMD?
UTMD has the lower trailing P/E at 22.5, versus 33.5 for INFU. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, InfuSystems or Utah Medical Products?
Utah Medical Products pays a dividend yielding 1.67%, while InfuSystems does not currently pay a regular dividend.
Are InfuSystems and Utah Medical Products in the same industry?
No. InfuSystems is in the Health Care sector, while Utah Medical Products is in Healthcare.